Skip to main content

IDWeek 2022 Main banner

Tweets by IDWeek 2022

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Back

Alexandre H. Watanabe, PharmD

Merck & Co., Inc.

Disclosure(s): Merck & Co., Inc.: Employee

Poster(s):

673 - Study of Prescribing patterns and Effectiveness of Ceftolozane/Tazobactam Real-world Analysis (SPECTRA): Results from a multi-national, multicenter observational study
Thursday, October 20, 2022
12:15 PM – 1:30 PM US ET